Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Pediatr. 2013 Jun 12;163(4):955–960.e1. doi: 10.1016/j.jpeds.2013.04.053

Table II.

Unadjusted patient outcomes during hospitalization by surfactant preparation

Outcome Beractant Calfactant Poractant alfa
Total ventilator days, median (interquartile range) 2 (1–7) 2 (1–7) 2 (0–5)
Necrotizing enterocolitis (medical & surgical), n (%) 1384 (6.8) 1191 (7.6) 1006 (6.6)
Intraventricular hemorrhage (grade III, IV), n (%) 1008 (5.0) 835 (5.3) 657 (4.3)
Pneumothorax, n (%) 1230 (6.0) 775 (4.9) 616 (4.1)
Pulmonary interstitial emphysema, n (%) 516 (2.5) 356 (2.3) 238 (1.6)
Air leak syndrome, n (%) 1589 (7.8) 1059 (6.7) 802 (5.3)
BPD, n (%) 3475 (17.6) 2480 (16.1) 1889 (12.9)
Death, n (%) 2052 (10.1) 1438 (9.1) 1086 (7.2)
Death or BPD, n (%) 5403 (27.4) 3848 (24.9) 2913 (19.9)